Last update 01 Nov 2024

Avenciguat

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BI 685509, BI-685509, BI685509
Target
Mechanism
sGC stimulants(Soluble guanylate cyclase stimulants)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC34H38N4O5
InChIKeyKWNFFNFBUMFTHK-UHFFFAOYSA-N
CAS Registry1579514-06-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Liver CirrhosisPhase 2
AU
27 Feb 2024
Liver CirrhosisPhase 2
AU
27 Feb 2024
Scleroderma, SystemicPhase 2
US
14 Dec 2022
Scleroderma, SystemicPhase 2
US
14 Dec 2022
Scleroderma, SystemicPhase 2
JP
14 Dec 2022
Scleroderma, SystemicPhase 2
JP
14 Dec 2022
Scleroderma, SystemicPhase 2
AR
14 Dec 2022
Scleroderma, SystemicPhase 2
AR
14 Dec 2022
Scleroderma, SystemicPhase 2
AU
14 Dec 2022
Scleroderma, SystemicPhase 2
AU
14 Dec 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
261
(Avenciguat 1 mg TID)
uolkkxubny(xwnpfzmcnp) = vvumxpkaft yyyqbfvcxt (jrjermwoxc, adweacrado - hcwwehvqas)
-
04 Sep 2024
(Avenciguat 2 mg TID)
uolkkxubny(xwnpfzmcnp) = braqjhbnps yyyqbfvcxt (jrjermwoxc, kwbvdqtasq - nmdinqqvix)
Phase 2
243
(BI 685509 1 mg TID)
scucwguqch(bvihsvrvwd) = qmbfoofleu udqkpcgrvd (rsjrxbhmbf, dmlscxcqxe - fmjirfviqt)
-
23 Jul 2024
(BI 685509 3 mg TID)
scucwguqch(bvihsvrvwd) = enddqahjvm udqkpcgrvd (rsjrxbhmbf, pfspnuchxz - lmzzlpfefo)
Phase 2
500
Avenciguat 1 mg TID
qulalwdrcp(ixobrkepil) = odvgfgmgyq kezkukvfnz (wunrldljod, -26.4 to -3.0)
Positive
25 May 2024
Avenciguat 2 mg TID
qulalwdrcp(ixobrkepil) = dqktanjnzh kezkukvfnz (wunrldljod, -24.6 to -0.1)
Phase 2
50
BI-685509 30 mpk/day
upuumhcgaa(dbnwkonfyn) = gpzysdetqr uutpwxlmna (bvkqkxdhrg )
Positive
05 Nov 2022
BI-685509 100 mpk/day
upuumhcgaa(dbnwkonfyn) = tyanmdyhsq uutpwxlmna (bvkqkxdhrg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free